High-Definition Spinal Cord Stimulation
Chronic Pain
UnknownActive
Key Facts
About Micro-Leads
Micro-Leads is pioneering next-generation, closed-loop neuromodulation with a focus on high-resolution, minimally-invasive devices. Its core platform integrates smart programmable electrodes, shape-memory percutaneous arrays, and custom application-specific integrated circuits (ASICs) to enable precise neural interfacing for chronic pain, sensory-motor paralysis, and other neurological disorders. The company is in the clinical development stage, positioning its technology as a potential solution for patients who have exhausted existing therapeutic options. Its innovative approach seeks to move neuromodulation from a broad, low-resolution intervention to a targeted, personalized medicine.
View full company profileTherapeutic Areas
Other Chronic Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| SCI-160 | SciSparc | Preclinical |
| Injectrode Platform for Chronic Pain | Neuronoff | Pre-clinical |
| Novel PNS System | Nervonik | First-in-Human Completed |
| Pain Pipeline | Centrexion Therapeutics | Clinical Stage |
| Precision Medicine for Pain | MindX Sciences | Commercial |
| Chronic Pain Program | Current Surgical | Research |
| N-19a | Neurocarrus | Pre-clinical |
| Nav1.7 ASO | Quiver Bioscience | Discovery |
| Nav1.8 ASO | Quiver Bioscience | Discovery |
| Dual Nav1.7/1.8 ASO | Quiver Bioscience | Discovery |
| TMS for Chronic Pain | Magstim | Commercial/Clinical Development |
| Platform Enhancements | Nevro | R&D |